SACCONI, RICCARDO
 Distribuzione geografica
Continente #
AS - Asia 2.454
NA - Nord America 2.028
EU - Europa 1.380
SA - Sud America 617
AF - Africa 64
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.560
Nazione #
US - Stati Uniti d'America 1.892
SG - Singapore 887
CN - Cina 827
BR - Brasile 518
IT - Italia 374
SE - Svezia 342
HK - Hong Kong 335
VN - Vietnam 172
RU - Federazione Russa 138
GB - Regno Unito 106
DE - Germania 102
CA - Canada 74
FI - Finlandia 73
IN - India 57
PL - Polonia 56
MX - Messico 50
FR - Francia 44
AR - Argentina 41
NL - Olanda 36
JP - Giappone 34
ZA - Sudafrica 32
ES - Italia 25
BD - Bangladesh 24
TR - Turchia 24
AT - Austria 21
IQ - Iraq 16
EC - Ecuador 15
LT - Lituania 15
AU - Australia 13
BE - Belgio 12
ID - Indonesia 12
IL - Israele 11
PH - Filippine 10
UY - Uruguay 10
MA - Marocco 9
VE - Venezuela 9
CO - Colombia 8
EG - Egitto 8
IE - Irlanda 8
AE - Emirati Arabi Uniti 7
PY - Paraguay 7
UZ - Uzbekistan 7
KR - Corea 6
UA - Ucraina 6
CH - Svizzera 5
CL - Cile 5
NP - Nepal 4
TN - Tunisia 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
KE - Kenya 3
NZ - Nuova Zelanda 3
PE - Perù 3
PK - Pakistan 3
PT - Portogallo 3
BH - Bahrain 2
CU - Cuba 2
DK - Danimarca 2
DZ - Algeria 2
GT - Guatemala 2
HR - Croazia 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
RO - Romania 2
RS - Serbia 2
SD - Sudan 2
SY - Repubblica araba siriana 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
MD - Moldavia 1
OM - Oman 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 6.560
Città #
Singapore 496
Ashburn 397
Hong Kong 334
Dallas 211
Shanghai 203
Hefei 142
Beijing 138
New York 121
Los Angeles 92
Milan 92
Lawrence 86
Princeton 86
Ho Chi Minh City 63
São Paulo 59
Hanoi 44
Warsaw 44
Helsinki 39
London 36
Moscow 36
Santa Clara 35
Tokyo 31
Brooklyn 27
Montreal 27
Poplar 26
Boardman 24
Johannesburg 24
The Dalles 23
Toronto 23
Orem 21
Rome 21
Chennai 20
Denver 20
Guangzhou 20
Boston 19
Chicago 19
Mexico City 19
Turku 19
Cesano Boscone 18
Munich 18
Stockholm 18
Atlanta 17
Nuremberg 17
Seattle 17
Phoenix 16
Amsterdam 15
Lappeenranta 15
Shenzhen 15
Manchester 14
Frankfurt am Main 13
Houston 13
Mumbai 13
Brasília 12
San Francisco 12
Vienna 12
Brussels 11
Columbus 11
Rio de Janeiro 11
Washington 11
Ankara 10
Charlotte 9
Bergamo 8
Brescia 8
Dublin 8
Guarulhos 8
Querétaro 8
Romagnano Sesia 8
Belo Horizonte 7
Biên Hòa 7
Contagem 7
Fortaleza 7
Istanbul 7
Naples 7
Porto Alegre 7
San Jose 7
Tashkent 7
Bari 6
Brisbane 6
Buenos Aires 6
Guayaquil 6
Haiphong 6
Hanover 6
Hải Dương 6
Ottawa 6
Quito 6
Ribeirão Preto 6
Roubaix 6
Salvador 6
Tianjin 6
Trento 6
Xi'an 6
Casablanca 5
Curitiba 5
Dhaka 5
Florence 5
Jiaxing 5
Manaus 5
Maronas 5
Piracicaba 5
Raleigh 5
Taizhou 5
Totale 3.706
Nome #
SAFETY AND EFFICACY OF SUBTHRESHOLD LASER IN THE TREATMENT OF RETICULAR PSEUDODRUSEN SECONDARY TO AGE-RELATED MACULAR DEGENERATION 108
Perifoveal exudative vascular anomalous complex in a highly myopic eye 100
Towards a better understanding of non-exudative choroidal and macular neovascularization 89
Nascent Geographic Atrophy as a Predictor of Type 3 Macular Neovascularization Development 84
A Review of Current and Future Management of Geographic Atrophy 83
A Brazilian case of exudative perifoveal vascular anomalous complex responsive to aflibercept intravitreal injections 82
Long-term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes with Diabetic Macular Edema treated with Anti-VEGF Therapy 77
CHOROIDAL VASCULARITY INDEX IN HYDROXYCHLOROQUINE TOXIC RETINOPATHY: A Quantitative Comparative Analysis Using Enhanced Depth Imaging In Spectral Domain Optical Coherence Tomography 76
Choroidal vascularity index in leptochoroid: A comparative analysis between reticular pseudodrusen and high myopia 74
OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With “Resolved” Chronic Central Serous Chorioretinopathy 73
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF THE DIABETIC MACULA: A Comparison Study Among Different Algorithms 73
A COMMON FINDING IN FOVEAL-SPARING EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN IMPLICATES BASAL LAMINAR DEPOSITS 67
Combined wide-field imaging in grading diabetic retinopathy 67
Choriocapillaris flow impairment could predict the enlargement of geographic atrophy lesion 67
OCT-A characterisation of recurrent type 3 macular neovascularisation 66
Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect” 66
Retinal Vein Occlusion Following Two Doses of mRNA-1237 (Moderna) Immunization for SARS-Cov-2: A Case Report 65
Comparison of peripheral extension, acquisition time, and image chromaticity of Optos, Clarus, and EIDON systems 64
Photoreceptor alteration in intermediate age-related macular degeneration 63
Choroidal vascularity index is associated with geographic atrophy progression 62
Ocular Toxicity of Mirvetuximab 61
Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting 61
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 61
Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy 61
Characterisation of macular neovascularisation in geographic atrophy 61
Choroidal cleft simulating choroidal caverns in neovascular age-related macular degeneration 60
Multimodal Imaging of Peripapillary hyperreflective ovoid mass-like structures (PHOMS) 60
Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease 59
Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes 59
CHORIOCAPILLARIS FLOW IMPAIRMENT IN TYPE 3 MACULAR NEOVASCULARIZATION: A Quantitative Analysis Using Swept-Source Optical Coherence Tomography Angiography 58
Artificial intelligence's role in differentiating the origin for subretinal bleeding in pathologic myopia 57
Longitudinal follow-up and outcome analysis in central serous chorioretinopathy 57
Acute macular neuroretinopathy as the first stage of SARS-CoV-2 infection 56
OCT Predictors of 3-Year Visual Outcome for Type 3 Macular Neovascularization 56
SWEPT-SOURCE AND SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS DYE ANGIOGRAPHY IN THE MEASUREMENT OF TYPE 1 NEOVASCULARIZATION 56
Choroidal Rift: A New OCT Finding in Eyes with Central Serous Chorioretinopathy 56
Choroideremia: Update On Clinical Features And Emerging Treatments 56
The covid-19 pandemic has had negative effects on baseline clinical presentation and outcomes of patients with newly diagnosed treatment-naïve exudative amd 56
Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study 56
Correlation between AI-measured lacquer cracks extension and development of myopic choroidal neovascularization 55
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study 55
In vivo rotational three-dimensional OCTA analysis of microaneurysms in the human diabetic retina 55
Dimple in vascularized serous pigment epithelial detachment secondary to neovascular age-related macular degeneration 54
Optical coherence tomography angiography characterization of evolving lesions in fellow eyes of exudative type 3 macular neovascularization patients 53
Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic 53
The "Sponge sign": A novel feature of inflammatory choroidal neovascularization 53
Multimodal imaging characterization of peripheral drusen 53
Three-year OCT predictive factors of disease recurrence in eyes with successfully treated myopic choroidal neovascularisation 53
Gliotic tissue simulating a macular neovascularization in full-thickness macular hole 53
Deep learning to distinguish Best vitelliform macular dystrophy (BVMD) from adult-onset vitelliform macular degeneration (AVMD) 52
Bilateral asymptomatic macular hypopigmentation in a young woman: multimodal imaging and pathogenetic hypothesis 52
Perifoveal Vascular Anomalous Complex and the Spectrum of Degenerative Microvascular Macular Diseases 52
Choroidal luminal and stromal areas and choriocapillaris perfusion are characterised by a non-linear quadratic relation in healthy eyes 52
Nonexudative Perifoveal Vascular Anomalous Complex: The Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 52
Guidelines on Optical Coherence Tomography Angiography Imaging: 2020 Focused Update 52
Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema 52
Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices 51
Prognostic role of optical coherence tomography after switch to dexamethasone in diabetic macular edema 51
Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine 51
Complications associated with worse visual outcomes in patients with exudative neovascular age-related macular degeneration 51
Longitudinal evaluation of the development of wedge-shaped subretinal hyporeflectivity in geographic atrophy 50
SUB-RETINAL PIGMENT EPITHELIUM MULTILAMINAR HYPERREFLECTIVITY AT THE ONSET OF TYPE 3 MACULAR NEOVASCULARIZATION 50
The retinal neurovascular coupling is impaired in men with vasculogenic erectile dysfunction 49
CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LONG-CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY 49
Subretinal Pseudocysts: A Comprehensive Analysis of this Novel OCT Finding 48
Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy 47
Deep-learning based automated quantification of critical optical coherence tomography features in neovascular age-related macular degeneration 47
Letter to the Editor: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy 47
One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study 47
Presumed Natural History of Combined Hamartoma of the Retina and Retinal Pigment Epithelium 47
Comparison of Retinal Nerve Fiber Layer and Ganglion Cell–Inner Plexiform Layer Thickness Values Using Spectral-Domain and Swept-Source OCT 46
Recognition, diagnosis and treatment of chorioretinal folds: Current perspectives 46
Diabetic macular ischemia 45
Regarding "Altered Blood Flow in the Ophthalmic and Internal Carotid Arteries in Patients with Age-Related Macular Degeneration Measured Using Noncontrast MR Angiography at 7T" 45
Functionality of retinal vessels in central serous retinopathy: A comparison between eplerenone and photodynamic therapy 45
Management of a unique case of Coats'-like X-linked retinitis pigmentosa associated with a RPGR variant in the era of anti-VEGF 45
The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration 44
Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease 44
Subclinical Angioid Streaks with Pseudodrusen: A New Phenotype of Age-Related Macular Degeneration 43
Choroidal Round Hyporeflectivities in Geographic Atrophy 43
Spectrally Resolved Fundus Autofluorescence in Healthy Eyes: Repeatability and Topographical Analysis of the Green-Emitting Fluorophores 43
Reply to Comment on OCT Risk Factors for 3-Year Development of Macular Complications in eyes with “Resolved” Chronic Central Serous Chorioretinopathy 43
Longitudinal assessment of type 3 macular neovascularization using three-dimensional volume-rendering OCTA 43
Bilateral choroidal caverns in a child with pachychoroid and anxious personality 43
INNER AND OUTER CHOROIDAL CHANGES IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY 42
TriPla Regimen: A new treatment approach for patients with neovascular age-related macular degeneration in the COVID-19 "era" 42
Optical coherence tomography angiography in diabetes 42
Discerning Between Macular Hemorrhages Due to Macular Neovascularization or Due to Spontaneous Bruch’s Membrane Rupture in High Myopia: A Comparative Analysis Between OCTA and Fluorescein Angiography 42
Progressive resolution of exudation from perifoveal vascular anomalous complex: A possible role of diclofenac therapy? 42
Real-Life Experience and Predictors of Visual Outcomes with Intravitreal Brolucizumab Switch for Treatment of Neovascular Age-Related Macular Degeneration 41
Reply to: Non-Exudative Perifoveal Vascular Anomalous Complex: the Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 41
Management of patients with diabetic macular oedema and good visual acuity: new findings from Protocol V 41
OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy 41
Nonmydriatic widefield retinal imaging with an automatic white LED confocal imaging system compared with dilated ophthalmoscopy in screening for diabetic retinopathy 41
No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy 41
Letter to the Editor regarding "Ophthalmic artery angioplasty for age-related macular degeneration" 40
Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy 40
Rotational Three-dimensional OCTA: a Notable New Imaging Tool to Characterize Type 3 Macular Neovascularization 40
Multimodal imaging to detect in vivo responses to aflibercept therapy in a mouse model of type 3 neovascularization 40
Optical coherence tomography angiography in pseudophakic cystoid macular oedema compared to diabetic macular oedema: qualitative and quantitative evaluation of retinal vasculature 39
Totale 5.472
Categoria #
all - tutte 52.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 60 1 0 0 0 0 0
2021/2022111 0 0 0 60 14 1 12 6 4 2 3 9
2022/2023631 210 134 45 9 4 71 14 10 60 47 9 18
2023/2024696 15 57 77 173 63 126 6 67 9 28 33 42
2024/20252.201 252 99 94 80 158 202 275 239 225 226 142 209
2025/20263.073 536 550 335 864 642 146 0 0 0 0 0 0
Totale 6.778